Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Scilex Holding (SCLXW) Cash & Equivalents (2020 - 2025)

Scilex Holding has reported Cash & Equivalents over the past 6 years, most recently at $213.0 million for Q3 2025.

  • Quarterly results put Cash & Equivalents at $213.0 million for Q3 2025, up 212884.0% from a year ago — trailing twelve months through Sep 2025 was $213.0 million (up 212884.0% YoY), and the annual figure for FY2024 was $3.3 million, down 16.55%.
  • Cash & Equivalents for Q3 2025 was $213.0 million at Scilex Holding, up from $4.1 million in the prior quarter.
  • Over the last five years, Cash & Equivalents for SCLXW hit a ceiling of $213.0 million in Q3 2025 and a floor of $34961.0 in Q3 2022.
  • Median Cash & Equivalents over the past 5 years was $2.2 million (2022), compared with a mean of $15.1 million.
  • Biggest five-year swings in Cash & Equivalents: plummeted 95.0% in 2024 and later skyrocketed 212884.0% in 2025.
  • Scilex Holding's Cash & Equivalents stood at $4.3 million in 2021, then tumbled by 49.65% to $2.2 million in 2022, then soared by 79.53% to $3.9 million in 2023, then decreased by 16.55% to $3.3 million in 2024, then soared by 6409.29% to $213.0 million in 2025.
  • The last three reported values for Cash & Equivalents were $213.0 million (Q3 2025), $4.1 million (Q2 2025), and $5.8 million (Q1 2025) per Business Quant data.